Academic literature on the topic 'Ebola virus disease – Political aspects'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Ebola virus disease – Political aspects.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Ebola virus disease – Political aspects"

1

Stellmach, Darryl, Isabel Beshar, Juliet Bedford, Philipp du Cros, and Beverley Stringer. "Anthropology in public health emergencies:what is anthropology good for?" BMJ Global Health 3, no. 2 (March 2018): e000534. http://dx.doi.org/10.1136/bmjgh-2017-000534.

Full text
Abstract:
Recent outbreaks of Ebola virus disease (2013–2016) and Zika virus (2015–2016) bring renewed recognition of the need to understand social pathways of disease transmission and barriers to care. Social scientists, anthropologists in particular, have been recognised as important players in disease outbreak response because of their ability to assess social, economic and political factors in local contexts. However, in emergency public health response, as with any interdisciplinary setting, different professions may disagree over methods, ethics and the nature of evidence itself. A disease outbreak is no place to begin to negotiate disciplinary differences. Given increasing demand for anthropologists to work alongside epidemiologists, clinicians and public health professionals in health crises, this paper gives a basic introduction to anthropological methods and seeks to bridge the gap in disciplinary expectations within emergencies. It asks: ‘What can anthropologists do in a public health crisis and how do they do it?’ It argues for an interdisciplinary conception of emergency and the recognition that social, psychological and institutional factors influence all aspects of care.
APA, Harvard, Vancouver, ISO, and other styles
2

Saxena, Abha, Paul André Bouvier, Ehsan Shamsi-Gooshki, Johannes Köhler, and Lisa J. Schwartz. "WHO guidance on ethics in outbreaks and the COVID-19 pandemic: a critical appraisal." Journal of Medical Ethics 47, no. 6 (March 31, 2021): 367–73. http://dx.doi.org/10.1136/medethics-2020-106959.

Full text
Abstract:
In 2016, following pandemic influenza threats and the 2014–2016 Ebola virus disease outbreaks, the WHO developed a guidance document for managing ethical issues in infectious disease outbreaks. In this article, we analyse some ethical issues that have had a predominant role in decision making in response to the current COVID-19 pandemic but were absent or not addressed in the same ways in the 2016 guidance document. A pandemic results in a health crisis and social and political crises both nationally and globally. The ethical implications of these global effects should be properly identified so that appropriate actions can be taken globally and not just in national isolation. Our analysis, which is a starting point to test the broader relevance of the 2016 WHO document that remains the only available guidance document applicable globally, concludes that the WHO guidance should be updated to provide reasoned and thoughtful comprehensive ethics advice for the sound management of the current and future pandemics.
APA, Harvard, Vancouver, ISO, and other styles
3

Obeng-Odoom, Franklin, and Matthew Marke Beckhio Bockarie. "The Political Economy of the Ebola Virus Disease." Social Change 48, no. 1 (March 2018): 18–35. http://dx.doi.org/10.1177/0049085717743832.

Full text
Abstract:
Public health has much to contribute to the global understanding and action on the past, present and future of Ebola but it is currently constrained by the construction of the ‘risk’ of catching Ebola. There has been a consequential emphasis on ‘health systems’, which has deflected attention from social alienation and implosion of social ties at the family, community, national and regional levels, instead justifying a colonial top-down response strategy. Indeed, that neglects class and social relations. It follows that the response strategy has reinforced social barriers that stand in the way of the development of social medicine, collective self-reliance in Africa, empowering social ties, social protection and socially inclusive development. What is needed, then, is not public health but critical postcolonial public health to pull down these impediments and develop socially sensitive alternatives that prioritise social relations and ties, inclusivity of diversity and complexity in African societies.
APA, Harvard, Vancouver, ISO, and other styles
4

Knežević, Darija, and Duška Jović. "Ebola 2014 - unprecedented epidemic / Ebola 2014 – epidemija bez presedana." SESTRINSKI ŽURNAL 2, no. 2 (October 21, 2015): 11. http://dx.doi.org/10.7251/sez0215011k.

Full text
Abstract:
Ebola, previously known as Ebola hemorrhagic fever, is a rare and deadly disease caused by infection with one of the Ebola virus strains. Starting from February 2014, the Ebola virus outbreak had spread across West African countries within a few months and caused great concerns of the World Health Organization. Currently there are no effective vaccines and drugs that are available for the prevention and treatment of infection with Ebola virus. Medical personnel caring for patients with suspect or confirmed Ebola viral disease is particularly exposed to the risk of suffering from this dangerous disease. It is important for frontline medical providers to understand key aspects of Ebola virus disease to quickly recognize an imported case, provide appropriate medical care, and prevent transmission. This paper gives a brief overview of the epidemics and pandemics, the biological characteristics of Ebola virus, the potential antiviral drugs and vaccines, as well as preventive measures.* 31 . July 2015, is said to have discovered an effective vaccine against Ebola virus http://www.thelancet.com/pb/assets/raw/Lancet/pdfs/S0140673615611175.pdf (note editor).
APA, Harvard, Vancouver, ISO, and other styles
5

Gilbert, Gwendolyn Lesley, and Ian Kerridge. "Communication and Communicable Disease Control: Lessons From Ebola Virus Disease." American Journal of Bioethics 15, no. 4 (April 3, 2015): 62–65. http://dx.doi.org/10.1080/15265161.2015.1009564.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jain, Sahil, Ekaterina Martynova, Albert Rizvanov, Svetlana Khaiboullina, and Manoj Baranwal. "Structural and Functional Aspects of Ebola Virus Proteins." Pathogens 10, no. 10 (October 15, 2021): 1330. http://dx.doi.org/10.3390/pathogens10101330.

Full text
Abstract:
Ebola virus (EBOV), member of genus Ebolavirus, family Filoviridae, have a non-segmented, single-stranded RNA that contains seven genes: (a) nucleoprotein (NP), (b) viral protein 35 (VP35), (c) VP40, (d) glycoprotein (GP), (e) VP30, (f) VP24, and (g) RNA polymerase (L). All genes encode for one protein each except GP, producing three pre-proteins due to the transcriptional editing. These pre-proteins are translated into four products, namely: (a) soluble secreted glycoprotein (sGP), (b) Δ-peptide, (c) full-length transmembrane spike glycoprotein (GP), and (d) soluble small secreted glycoprotein (ssGP). Further, shed GP is released from infected cells due to cleavage of GP by tumor necrosis factor α-converting enzyme (TACE). This review presents a detailed discussion on various functional aspects of all EBOV proteins and their residues. An introduction to ebolaviruses and their life cycle is also provided for clarity of the available analysis. We believe that this review will help understand the roles played by different EBOV proteins in the pathogenesis of the disease. It will help in targeting significant protein residues for therapeutic and multi-protein/peptide vaccine development.
APA, Harvard, Vancouver, ISO, and other styles
7

Jaskaran Singh, Thapa Komal, Sandeep Arora, Amarjot Kaur, and Thakur Gurjeet Singh. "Ebola Hemorrhagic Fever: Recent Update On Disease Status, Current Therapies And Advances In Treatment." Journal of Pharmaceutical Technology, Research and Management 5, no. 2 (November 2, 2017): 217–34. http://dx.doi.org/10.15415/jptrm.2017.52013.

Full text
Abstract:
Swiftly growing viruses are a major intimidation to human health. Such viruses are extremely pathogenic like Ebola virus, influenza virus, HIV virus, Zika virus etc . Ebola virus, a type of Filovirus, is an extremely infectious, single-stranded ribonucleic acid virus that infects both humans and apes, prompting acute fever with hemorrhagic syndrome. The high infectivity, severity and mortality of Ebola has plagued the world for the past fifty years with its first outbreak in 1976 in Marburg, Germany, and Frankfurt along with Belgrade and Serbia. The world has perceived about 28,000 cases and over 11,000 losses. The high lethality of Ebola makes it a candidate for use in bioterrorism thereby arising more concern. New guidelines have been framed for providing best possible care to the patients suffering from Ebola virus i.e Grading of Recommendation Assessment, Development And Evaluation (GRADE) methodology to develop evidence-based strategy for the treatment in future outbreak of Ebola virus. No drugs have been approved, while many potent drugs like rVSV-EBOV, Favipiravir, ZMapp are on clinical test for human safety. In this review we will discover and discuss perspective aspects that lead to the evolution of different Ebola variants as well as advances in various drugs and vaccines for treatment of the disease.
APA, Harvard, Vancouver, ISO, and other styles
8

Kozak, Robert, Shihua He, Andrea Kroeker, Marc-Antoine de La Vega, Jonathan Audet, Gary Wong, Chantel Urfano, et al. "Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease." Journal of Virology 90, no. 20 (August 3, 2016): 9209–23. http://dx.doi.org/10.1128/jvi.01033-16.

Full text
Abstract:
ABSTRACTBundibugyo virus (BDBV) is the etiological agent of a severe hemorrhagic fever in humans with a case-fatality rate ranging from 25 to 36%. Despite having been known to the scientific and medical communities for almost 1 decade, there is a dearth of studies on this pathogen due to the lack of a small animal model. Domestic ferrets are commonly used to study other RNA viruses, including members of the orderMononegavirales. To investigate whether ferrets were susceptible to filovirus infections, ferrets were challenged with a clinical isolate of BDBV. Animals became viremic within 4 days and succumbed to infection between 8 and 9 days, and a petechial rash was observed with moribund ferrets. Furthermore, several hallmarks of human filoviral disease were recapitulated in the ferret model, including substantial decreases in lymphocyte and platelet counts and dysregulation of key biochemical markers related to hepatic/renal function, as well as coagulation abnormalities. Virological, histopathological, and immunohistochemical analyses confirmed uncontrolled BDBV replication in the major organs. Ferrets were also infected with Ebola virus (EBOV) to confirm their susceptibility to another filovirus species and to potentially establish a virus transmission model. Similar to what was seen with BDBV, important hallmarks of human filoviral disease were observed in EBOV-infected ferrets. This study demonstrates the potential of this small animal model for studying BDBV and EBOV using wild-type isolates and will accelerate efforts to understand filovirus pathogenesis and transmission as well as the development of specific vaccines and antivirals.IMPORTANCEThe 2013-2016 outbreak of Ebola virus in West Africa has highlighted the threat posed by filoviruses to global public health. Bundibugyo virus (BDBV) is a member of the genusEbolavirusand has caused outbreaks in the past but is relatively understudied, likely due to the lack of a suitable small animal model. Such a model for BDBV is crucial to evaluating vaccines and therapies and potentially understanding transmission. To address this, we demonstrated that ferrets are susceptible models to BDBV infection as well as to Ebola virus infection and that no virus adaptation is required. Moreover, these animals develop a disease that is similar to that seen in humans and nonhuman primates. We believe that this will improve the ability to study BDBV and provide a platform to test vaccines and therapeutics.
APA, Harvard, Vancouver, ISO, and other styles
9

Lambe, Teresa, Georgina Bowyer, and Katie J. Ewer. "A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?" Philosophical Transactions of the Royal Society B: Biological Sciences 372, no. 1721 (April 10, 2017): 20160295. http://dx.doi.org/10.1098/rstb.2016.0295.

Full text
Abstract:
Sporadic outbreaks of Ebola virus infection have been documented since the mid-Seventies and viral exposure can lead to lethal haemorrhagic fever with case fatalities as high as 90%. There is now a comprehensive body of data from both ongoing and completed clinical trials assessing various vaccine strategies, which were rapidly advanced through clinical trials in response to the 2013–2016 Ebola virus disease (EVD) public health emergency. Careful consideration of immunogenicity post vaccination is essential but has been somewhat stifled because of the wide array of immunological assays and outputs that have been used in the numerous clinical trials. We discuss here the different aspects of the immune assays currently used in the Phase I clinical trials for Ebola virus vaccines, and draw comparisons across the immune outputs where possible; various trials have examined both cellular and humoral immunity in European and African cohorts. Assessment of the safety data, the immunological outputs and the ease of field deployment for the various vaccine modalities will help both the scientific community and policy-makers prioritize and potentially license vaccine candidates. If this can be achieved, the next outbreak of Ebola virus, or other emerging pathogen, can be more readily contained and will not have such widespread and devastating consequences. This article is part of the themed issue ‘The 2013–2016 West African Ebola epidemic: data, decision-making and disease control’.
APA, Harvard, Vancouver, ISO, and other styles
10

Dhanya, Chandrasekharan Rajalekshmi, Aswathy Shailaja, Aarcha Shanmugha Mary, Sumodan Padikkala Kandiyil, Ambili Savithri, Vishnu Sasidharan Lathakumari, Jayakrishnan Therthala Veettil, Jiji Joseph Vandanamthadathil, and Maya Madhavan. "RNA Viruses, Pregnancy and Vaccination: Emerging Lessons from COVID-19 and Ebola Virus Disease." Pathogens 11, no. 7 (July 15, 2022): 800. http://dx.doi.org/10.3390/pathogens11070800.

Full text
Abstract:
Pathogenic viruses with an RNA genome represent a challenge for global human health since they have the tremendous potential to develop into devastating pandemics/epidemics. The management of the recent COVID-19 pandemic was possible to a certain extent only because of the strong foundations laid by the research on previous viral outbreaks, especially Ebola Virus Disease (EVD). A clear understanding of the mechanisms of the host immune response generated upon viral infections is a prime requisite for the development of new therapeutic strategies. Hence, we present here a comparative study of alterations in immune response upon SARS-CoV-2 and Ebola virus infections that illustrate many common features. Vaccination and pregnancy are two important aspects that need to be studied from an immunological perspective. So, we summarize the outcomes and immune responses in vaccinated and pregnant individuals in the context of COVID-19 and EVD. Considering the significance of immunomodulatory approaches in combating both these diseases, we have also presented the state of the art of such therapeutics and prophylactics. Currently, several vaccines against these viruses have been approved or are under clinical trials in various parts of the world. Therefore, we also recapitulate the latest developments in these which would inspire researchers to look for possibilities of developing vaccines against many other RNA viruses. We hope that the similar aspects in COVID-19 and EVD open up new avenues for the development of pan-viral therapies.
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Ebola virus disease – Political aspects"

1

Matua, Amandu Gerald. "Living under the threat of Ebola : a phenomenological study." Thesis, 2014. http://hdl.handle.net/10500/13822.

Full text
Abstract:
This study articulates the phenomenon of living under a constant threat of Ebola haemorrhagic fever, including what people’s reactions towards individuals and families affected by the illness symbolizes as well as the meanings ascribed to Ebola. The study was conducted in Kibale district in Midwestern Uganda to aid understanding of the human aspects of Ebola which has continued to result in widespread fear and anxiety, thereby creating challenges for affected individuals, families and health care professionals. A phenomenological inquiry was undertaken using Wertz’s (1983, 2005, 2011) empirical psychological reflection approach for data analysis, after utilizing purposive, convenience and criterion sampling techniques to select twelve (12) adult survivors and caregivers who anticipated, experienced and survived the outbreak and were in good health and also willing to take part in the study. Data were generated using in-depth qualitative interviews and the interviews continued until data redundancy was reached. The interview proceedings were digitally audio-recorded in addition to taking field notes and these were transcribed verbatim. Data analysis occurred at idiographic and nomothetic levels according to the principles of Wertz’s empirical psychological reflection. Thematic analysis of the research data revealed seven (7) themes, namely:  Living under constant threat of Ebola  Nature of Ebola experience: unique and general meanings  Surviving Ebola: physical, psychological, social, spiritual and economic implications on survivors  Caring for Ebola patients: social and psychological implications  Public reaction toward persons affected by Ebola  Social-cultural beliefs and practices related to Ebola  Coping with and living in the aftermath of Ebola outbreaks Adaptation emerged as the single most encompassing and accommodating concept that united the various themes, categories and sub-categories. It further grounded survivors’, caregivers’ and community’s experience of anticipating, experiencing and coping with challenges associated with Ebola. The findings add substantial knowledge about how survivors and caregivers experience Ebola outbreaks. Important recommendations are made and guidelines that may be used to increase survivors’, caregivers’ as well as the community’s resilience to challenges of future Ebola outbreaks are suggested.
Health Studies
D. Lit. et Phil. (Health Science)
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Ebola virus disease – Political aspects"

1

Virus alert: Security, governmentality, and the AIDS pandemic. New York: Columbia University Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

H, Boykin James. Essays on AIDS: An introduction to the influence of a virus on politics. Miami: J.H. Boykin, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

The psychosocial aspects of a deadly epidemic: What ebola has taught us about holistic healing. Santa Barbara, California: Praeger/ABC-CLIO, LLC, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kerry, Cullinan, and Thom Anso, eds. The virus, vitamins and vegetables: The South African HIV/AIDS mystery. Auckland Park, South Africa: Jacana, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Abdullah, Ibrahim, and Ismail Rashid. Understanding West Africa's Ebola Epidemic: Towards a Political Economy. Zed Books, Limited, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Abdullah, Ibrahim, and Ismail Rashid. Understanding West Africa's Ebola Epidemic: Towards a Political Economy. Zed Books, Limited, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Understanding West Africa's Ebola Epidemic: Towards a Political Economy. Zed Books, Limited, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Abdullah, Ibrahim, and Ismail Rashid. Understanding West Africa's Ebola Epidemic: Towards a Political Economy. Zed Books, Limited, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Elbe, Stefan. Virus Alert. Columbia University Press, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

World Health Organization (WHO). Water Safety in Distribution Systems. World Health Organization, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Ebola virus disease – Political aspects"

1

Qureshi, Adnan I. "Economic and Political Impact of Ebola Virus Disease." In Ebola Virus Disease, 177–91. Elsevier, 2016. http://dx.doi.org/10.1016/b978-0-12-804230-4.00013-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Qureshi, Mushtaq H. "Economic and political aspects of Dengue virus disease." In Dengue Virus Disease, 151–58. Elsevier, 2020. http://dx.doi.org/10.1016/b978-0-12-818270-3.00009-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Ebola virus disease – Political aspects"

1

Lees, Shelley, and Mark Marchant. Key Considerations: Cross-Border Dynamics Between Uganda and Tanzania in the Context of the Outbreak of Ebola, 2022. Institute of Development Studies, December 2022. http://dx.doi.org/10.19088/sshap.2022.046.

Full text
Abstract:
This brief summarises key considerations concerning cross-border dynamics between Tanzania and Uganda in the context of the outbreak of Ebola (Sudan Virus Disease, SVD) in Uganda. It is part of a series focusing on at-risk border areas between Uganda and four high priority neighbouring countries: Rwanda; Tanzania; Kenya and South Sudan. The current outbreak is of the Sudan strain of Ebola (SVD). SVD is used in this paper to refer to the current outbreak in East Africa, whereas outbreaks of Zaire Ebolavirus disease or general references to Ebola are referred to as EVD. The current outbreak began in Mubende, Uganda, on 19 September 2022, approximately 240km from the Uganda-Tanzania border. It has since spread to nine Ugandan districts, including two in the Kampala metropolitan area. Kampala is a transport hub, with a population over 3.6 million. While the global risk from SVD remains low according to the World Health Organization, its presence in the Ugandan capital has significantly heightened the risk to regional neighbours. At the time of writing, there had been no cases of Ebola imported from Uganda into Tanzania. This brief provides details about cross-border relations, the political and economic dynamics likely to influence these, and specific areas and actors most at risk. It is based on a rapid review of existing published and grey literature, previous ethnographic research in Tanzania, and informal discussions with colleagues from the Tanzania’s Ministry of Health, Community Development, Gender, Elderly and Children (MoHCDGEC), Tanzania National Institute for Medical Research (NIMR), Uganda Red Cross Society, Tanzania Red Cross Society (TRCS), International Organization for Migration (IOM), IFRC, US CDC and CDC Tanzania. The brief was developed by Shelley Lees and Mark Marchant (London School of Hygiene & Tropical Medicine) with support from Olivia Tulloch (Anthrologica) and Hugh Lamarque (University of Edinburgh). Additional review and inputs were provided by The Tanzania Red Cross and UNICEF. The brief is the responsibility of the Social Science in Humanitarian Action Platform (SSHAP).
APA, Harvard, Vancouver, ISO, and other styles
2

Lamarque, Hugh. Key Considerations: Cross-Border Dynamics between Uganda and Rwanda in the Context of the Outbreak of Ebola, 2022. SSHAP, November 2022. http://dx.doi.org/10.19088/sshap.2022.044.

Full text
Abstract:
This brief summarises key considerations concerning cross-border dynamics between Uganda and Rwanda in the context of the 2022 outbreak of Ebola (Sudan Virus Disease, SVD) in Uganda. It is part of a series focusing on at-risk border areas between Uganda and four high priority neighbouring countries: Rwanda; Tanzania; Kenya; and South Sudan. The outbreak began in Mubende, Uganda on 19 September 2022, approximately 300 kilometres from the Uganda-Rwanda border. At the time of writing (November 2022) it has spread to nine Ugandan districts, including two in the Kampala metropolitan area. Kampala is a transport hub, with a population over 3.6 million. While the global risk from SVD remains low according to the World Health Organization, its presence in the Uganda capital has significantly heightened the risk to regional neighbours. Rwanda is categorised as Priority 1, with significant preparedness activities underway. As of November 2022, there had been no case of SVD imported from Uganda into Rwanda, although alerts have been triggered at border posts. This brief provides details about cross-border relations, the political and economic dynamics likely to influence these, and specific areas and actors most at risk. It is based on a rapid review of existing published and grey literature, news reports, previous ethnographic research in Rwanda and Uganda, and informal discussions with colleagues from Save the Children, UNICEF, UNECA, UNDP, IOM, TBI, and the World Bank. It was requested by the Collective Service, written by Hugh Lamarque (University of Edinburgh) and supported by Olivia Tulloch (Anthrologica. It was reviewed by colleagues from Save the Children, Anthrologica, the Institute of Development Studies and the Collective Service. This brief is the responsibility of SSHAP.
APA, Harvard, Vancouver, ISO, and other styles
3

Lamarque, Hugh, and Hannah Brown. Key Considerations: Cross-Border Dynamics Between Uganda and Kenya in the Context of the Outbreak of Ebola, 2022. Institute of Development Studies, December 2022. http://dx.doi.org/10.19088/sshap.2022.043.

Full text
Abstract:
This brief summarises key considerations concerning cross-border dynamics between Uganda and Kenya in the context of the outbreak of Ebola (Sudan Virus Disease, SVD) in Uganda. It is part of a series focusing on at-risk border areas between Uganda and four high priority neighbouring countries: Kenya; Rwanda; Tanzania, and South Sudan. The outbreak began in Mubende District, Uganda on 19 September 2022, approximately 340km from the Kenyan border. At the time of writing (December 2022), the outbreak had spread to eight Ugandan districts, including two in the Kampala metropolitan area. Kampala is a transport hub, with a population over 3.6 million. While the global risk from SVD remains low according to the World Health Organization (WHO), its presence in the Ugandan capital has significantly heightened the risk to regional neighbours. Kenya is categorised as a priority level 1 country, following a case in Jinja on the road between Kampala and the Kenyan border, on 13 November 2022. A total of 23 suspected cases were tested in Kenya up to 1 December 2022, all with negative results. To date, no case of SVD has been imported into the country from Uganda. This brief provides details about cross-border relations between the two states, the political and economic dynamics likely to influence these, and the specific areas and actors most at risk. The brief is based on a rapid review of existing published and grey literature, news reports, previous ethnographic research in Kenya and Uganda, and informal discussions with colleagues from the International Organisation for Migration, UNICEF, UNDP, Save the Children, the Kenyan Red Cross Society, the Kenyan Ministry of Health (MoH) and Ministry of Livestock, Agriculture and Fisheries in Kenya, and the Safe Water and AIDS project in Kisumu. It was requested by the Collective Service, written by Hugh Lamarque (University of Edinburgh) and Hannah Brown (Durham University) and supported by Olivia Tulloch (Anthrologica). It was further reviewed by colleagues from Anthrologica, the Institute of Development Studies, and the Collective Service. This brief is the responsibility of SSHAP.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography